Webinar Date/Time: Thursday, March 30th, 2023 at 10am EDT|7am PDT|3pm BST|4pm CEST
How to think about using connected devices to collect higher quality data and better enable the data flow for the trial as a whole – (can we use something form GLG work if this doesn’t make sense )
Accelerate the acquisition and validation of increasingly complex data sources and deliver new treatments to patients faster with an innovative and strategy-driven clinical data management solution from IQVIA.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1597232&tp_key=abbf637541
Event Overview:
Industry stakeholders have worked to enhance patient centricity in research and development in recent years in hopes of improving patient engagement and ensuring patients have a stronger voice in their clinical care.
This noticeable shift toward patient centricity also intends to help sponsors address long-standing challenges in successfully designing and executing clinical trials. Decentralized trial solutions are being validated in terms of accommodating patients’ needs to improve their trial experiences, which also benefits sponsors in reducing trial delays and related costs, without compromising patient safety or data quality.
Three key take-aways
Speakers:
Sabrina Steffen
Head of Data Strategy and Innovation for DSSM
IQVIA
Sabrina Steffen is the Head of Data Strategy and Innovation for Data Management, Biostatistics Connected Devices, Medical Safety Services and Lifecycle Safety. She is US-based and has worked in clinical research for 17 years, within data management, risk-based monitoring, data strategy, process improvement and innovation. Sabrina has led the Data Strategy and Innovation team for 6 years overseeing large scale process and technology transformations starting from inception, through delivery and change management to achieve fully embedded technology-enabled processes.
Greg Temesi
Senior Director, Connected Devices
IQVIA
Greg Temesi is a Senior Director at IQVIA Connected Devices, his objectives include but are not limited to frictionless study startups, best in class user experience, and global quality management. Before joining IQVIA he has held various roles with increasing responsibilities in multiple countries at MSD (Merck Sharp & Dohme). Most notably, he has been the head of R&D IT in EMEA and Japan, he has co-led the development of multiple regional innovations hubs and established a new function focusing on applied technologies in clinical trials. Earlier in his career Greg has built his own startup company and also filled different roles at IBM. Greg is based in Vienna, Austria; he holds double Master’s in Computer Science and Biomedical Engineering, and he has received his PhD in Molecular Genetics.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1597232&tp_key=abbf637541
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.